Drug research

VIR-3434

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Tobevibart

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.NCT05461170	VIR	Phase 2	Active not recruiting	2031-11Estimated
Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus InfectionNCT04856085	VIR	Phase 2	Completed	2026-03-16Actual

VIRActive not recruitingPrimary completion: 2031-11 · Estimated

Trial details

VIRCompletedPrimary completion: 2026-03-16 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.